Autopsy report · NCT00831441
Phase III Acute Coronary Syndrome
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years before it stopped.
- 7,484 participants enrolled.
- Results were posted on the registry 4 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Bristol-Myers Squibb
- Sponsor type
- Industry
- Conditions
- Acute Coronary Syndrome
- Interventions
- Apixaban; Placebo
- Participants
- 7,484
- Sites
- 1,012
- Countries
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czechia, Denmark and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.